[1]宋梦丽 李林锋.壳聚糖止血海绵在经桡动脉冠状动脉介入治疗术后的应用进展[J].心血管病学进展,2022,(6):506.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.007]
　SONG Mengli,LI Linfeng.Chitosan Hemostatic Sponge after Transradial Coronary Interventional Therapy[J].Advances in Cardiovascular Diseases,2022,(6):506.[doi:10.16806/j.cnki.issn.1004-3934.2022.06.007]
点击复制

壳聚糖止血海绵在经桡动脉冠状动脉介入治疗术后的应用进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2022年6期
页码:
506
栏目:
综述
出版日期:
2022-06-25

文章信息/Info

Title:
Chitosan Hemostatic Sponge after Transradial Coronary Interventional Therapy
作者:
宋梦丽1 李林锋 1; 2
(1.南昌大学医学院,江西 南昌 330000;2.江西省人民医院,江西 南昌 330000)
Author(s):
SONG Mengli1;  LI Linfeng1; 2
(1.Medical College of Nanchang University,Nanchang 330000, China2.Jiangxi Provincial People’s Hospital,Nanchang 330000,China)
关键词:
壳聚糖; 冠状动脉介入治疗; 止血; 桡动脉
Keywords:
Chitosan; Coronary intervention; Stop the bleeding; Radial artery
DOI:
10.16806/j.cnki.issn.1004-3934.2022.06.007
摘要:
随着冠状动脉介入治疗的蓬勃发展，桡动脉穿刺的手术方式在临床得到广泛运用，而桡动脉穿刺部位的止血工作也成为术后临床护理工作的重点内容之一。壳聚糖是一种天然的海洋碱性多糖，壳聚糖基敷料在止血过程中表现出良好的生物相容性和生物可降解性，同时还具有无毒、抗菌、止痛及促进愈合等优良特性。现就冠状动脉介入治疗术后的止血方法、壳聚糖的生物活性、壳聚糖复合止血材料及壳聚糖止血敷料在经桡动脉冠状动脉介入治疗术后的运用进展进行综述，为今后壳聚糖在冠状动脉介入治疗术后桡动脉止血的应用及发展提供理论依据。
Abstract:
With the rapid development of coronary intervention,radial artery puncture has been widely used in clinic,and the hemostasis of radial artery puncture site has become one of the key contents of postoperative clinical nursing work. Chitosan is a kind of natural Marine alkaline polysaccharide. Chitosan based dressings show good biocompatibility and biodegradability during hemostasis,and also have excellent properties such as non-toxic,antibacterial,analgesic and healing promotion. This article reviews the hemostatic methods after percutaneous coronary intervention,the biological activity of chitosan,the application of chitosan composite hemostatic material and the application progress of chitosan hemostatic dressing after transradial coronary interventional therapy,it provides a theoretical basis for the application and development of chitosan in radial artery hemostasis after percutaneous coronary intervention.

参考文献/References:


[1]Ng AK,Ng PY,Ip A,et al. Association between radial versus femoral access for percutaneous coronary intervention and long-term mortality[J]. J Am Heart Assoc,2021,10(15):e021256.

[2]Kolkailah AA,Alreshq RS,Muhammed AM,et al. Cochrane corner:is it better to access the coronary circulation via the radial or the femoral artery?[J]. Heart,2019,105(9):668-670.

[3]武宝峰,秦纲. 桡动脉止血器研究进展[J]. 中国循证心血管医学杂志,2021,13(6):766-768.

[4]Sandoval Y,Bell MR,Gulati R. Transradial artery access complications[J]. Circ Cardiovasc Interv,2019,12(11):e007386.

[5]武筱燕,潘江其,姚志萍. 经桡动脉行冠脉介入术后手腕部护理的研究进展[J]. 外科研究与新技术,2017,6(1):65-69.

[6]闵英,刘艳杰,赵妍,等. 弹力绷带法与气囊加压止血器对经桡动脉冠状动脉介入术后止血效果比较的单中心、前瞻性、随机对照研究[J]. 心脏杂志,2019,31(5):544-547,560.

[7]Cong X,Huang Z,Wu J,et al. Randomized comparison of 3 hemostasis techniques after transradial coronary intervention[J]. J Cardiovasc Nurs,2016,31(5):445-451.

[8]Pathan AZ,Aijaz S,Sheikh S,et al. Randomized trial comparing radial hemostasis techniques;catechol conjugated chitosan pad (InnoSEAL) versus pneumatic compression band[J]. Catheter Cardiovasc Interv,2021,98(2):E181-E187.

[9]Khan F,Pham DTN,Oloketuyi SF,et al. Chitosan and their derivatives:antibiofilm drugs against pathogenic bacteria[J]. Colloids Surf B Biointerfaces,2020,185:110627.

[10]Wang W,Meng Q,Li Q,et al. Chitosan derivatives and their application in biomedicine[J]. Int J Mol Sci,2020,21(2):487.

[11]Sung YK,Lee DR,Chung DJ. Advances in the development of hemostatic biomaterials for medical application[J]. Biomater Res,2021,25(1):37.

[12]Chen Y,Wu L,Li P,et al. Polysaccharide based hemostatic strategy for ultrarapid hemostasis[J]. Macromol Biosci,2020,20(4):e1900370.

[13]Khan MA,Mujahid M. A review on recent advances in chitosan based composite for hemostatic dressings[J]. Int J Biol Macromol,2019,124:138-147.

[14]Feng P,Luo Y,Ke C,et al. Chitosan-based functional materials for skin wound repair:mechanisms and applications[J]. Front Bioeng Biotechnol,2021,9:650598.

[15]杨志远,窦桂芳,甘慧,等. 壳聚糖改性材料的研究及在止血领域的应用[J]. 国际药学研究杂志,2020,47(8):609-613.

[16]Bano I,Arshad M,Yasin T,et al. Chitosan:a potential biopolymer for wound management[J]. Int J Biol Macromol,2017,102:380-383.

[17]Balagangadharan K,Dhivya S,Selvamurugan N. Chitosan based nanofibers in bone tissue engineering[J]. Int J Biol Macromol,2017,104(Pt B):1372-1382.

[18]Oryan A,Sahvieh S. Effectiveness of chitosan scaffold in skin,bone and cartilage healing[J]. Int J Biol Macromol,2017,104(Pt A):1003-1011.

[19]Senel S,McClure SJ. Potential applications of chitosan in veterinary medicine[J]. Adv Drug Deliv Rev,2004,56(10):1467-1480.

[20]Adnan S,Ranjha NM,Hanif M,et al. O-carboxymethylated chitosan;a promising tool with in-vivo anti-inflammatory and analgesic properties in albino rats[J]. Int J Biol Macromol,2020,156:531-536.

[21]Belbekhouche S,Bousserrhine N,Alphonse V,et al. Chitosan based self-assembled nanocapsules as antibacterial agent[J]. Colloids Surf B Biointerfaces,2019,181:158-165.

[22]Cheah WY,Show PL,Ng IS,et al. Antibacterial activity of quaternized chitosan modified nanofiber membrane[J]. Int J Biol Macromol,2019,126:569-577.

[23]薛金玲,李健军,白艳红,等. 壳聚糖及其衍生物抗菌活性的研究进展[J]. 高分子通报,2017,(11):26-36.

[24]Moeini A,Pedram P,Makvandi P,et al. Wound healing and antimicrobial effect of active secondary metabolites in chitosan-based wound dressings:a review[J]. Carbohydr Polym,2020,233:115839.

[25]Wang CH,Cherng JH,Liu CC,et al. Procoagulant and antimicrobial effects of chitosan in wound healing[J]. Int J Mol Sci,2021,22(13):7067.

[26]Zheng C,Zeng Q,Pimpi S,et al. Research status and development potential of composite hemostatic materials[J]. J Mater Chem B,2020,8(25):5395-5410.

[27]Fan X,Li M,Yang Q,et al. Morphology-controllable cellulose/chitosan sponge for deep wound hemostasis with surfactant and pore-foaming agent[J]. Mater Sci Eng C Mater Biol Appl,2021,118:111408.

[28]Sakthiguru N,Sithique MA. Fabrication of bioinspired chitosan/gelatin/allantoin biocomposite film for wound dressing application[J]. Int J Biol Macromol,2020,152:873-883.

[29]He Y,Zhao W,Dong Z,et al. A biodegradable antibacterial alginate/carboxymethyl chitosan/Kangfuxin sponges for promoting blood coagulation and full-thickness wound healing[J]. Int J Biol Macromol,2021,167:182-192.

[30]徐美芳. 壳聚糖止血敷料在经桡动脉冠状动脉介入治疗术后止血中的应用[J]. 医学信息,2014,(1):88-89.

[31]Dai N,Xu DC,Hou L,et al. A comparison of 2 devices for radial artery hemostasis after transradial coronary intervention[J]. J Cardiovasc Nurs,2015,30(3):192-196.

[32]刘志郎,马建亮,徐增政,等. 壳聚糖护创海绵在经桡动脉介入后穿刺部位止血效果观察[J]. 医学理论与实践,2016,29(7):879-881.

[33]Sattar S,Aijaz S,Akhter Z,et al. Comparison of two radial hemostasis techniques,catechol conjugated chitosan-based pad (InnoSEAL) with compression band:a randomized controlled trial[J]. J Am Coll Cardiol,2019,73(9):1391.

[34]索旻,聂绍平,艾辉,等. 经桡动脉穿刺冠状动脉介入治疗后应用新型止血材料联合动脉压迫装置的止血效果研究[J]. 中国医药,2019,14(7):977-980.

[35]Kang SH,Han D,Kim S,et al. Hemostasis pad combined with compression device after transradial coronary procedures:a randomized controlled trial[J]. PLoS One,2017,12(7):e0181099.

[36]Roberts JS,Niu J,Pastor-Cervantes JA. Comparison of hemostasis times with a chitosan-based hemostatic pad (Clo-SurPlusRadial?) vs mechanical compression (TR Band?) following transradial access:a pilot study[J]. Cardiovasc Revasc Med,2019,20(10):871-874.

[37]Anchan R,Venturini J,Larsen P,et al. Safe and rapid radial hemostasis achieved using a novel topical hemostatic patch:results of a first-in-human pilot study using hydrophobically modified polysaccharide-chitosan[J]. Catheter Cardiovasc Interv,2022,99(3):786-794.

相似文献/References:

[1]李润土,何泉.光学相干断层成像在急性冠脉综合征介入治疗中的应用[J].心血管病学进展,2019,(6):856.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.005]
　LI Runtu,HE Quan.Application of Optical Coherent Tomography in Interventional Treatment of Acute Coronary Syndrome[J].Advances in Cardiovascular Diseases,2019,(6):856.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.005]
[2]安明春,杨旭明.冠状动脉慢性完全闭塞病变介入治疗及临床获益研究进展[J].心血管病学进展,2019,(6):860.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.006]
　AN Mingchun,YANG Xuming.Research Progress in Interventional Therapy and Clinical Benefits of CTO Lesions[J].Advances in Cardiovascular Diseases,2019,(6):860.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.006]
[3]张海福 张邢炜.血液透析患者冠状动脉介入治疗术后双联抗血小板治疗的进展[J].心血管病学进展,2020,(12):1281.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.014]
　ZHANG Haifu,ZHANG Xingwei.Dual Antiplatelet Therapy after Coronary Intervention in Hemodialysis Patients[J].Advances in Cardiovascular Diseases,2020,(6):1281.[doi:10.16806/j.cnki.issn.1004-3934.2020.12.014]

更新日期/Last Update: 2022-08-05